These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

274 related items for PubMed ID: 32801088

  • 21. Synthesis, molecular modeling and cholinesterase inhibitory effects of 2-indolinone-based hydrazinecarbothioamides.
    Demir-Yazıcı K, Apaydın ÇB, Soylu-Eter Ö, Özsoy N, Karalı N.
    Future Med Chem; 2021 Dec; 13(24):2133-2151. PubMed ID: 34755546
    [Abstract] [Full Text] [Related]

  • 22. Synthesis, Biological Evaluation and Molecular Docking Study of Hydrazone-Containing Pyridinium Salts as Cholinesterase Inhibitors.
    Parlar S, Bayraktar G, Tarikogullari AH, Alptüzün V, Erciyas E.
    Chem Pharm Bull (Tokyo); 2016 Dec; 64(9):1281-7. PubMed ID: 27581632
    [Abstract] [Full Text] [Related]

  • 23. Tertiary amine derivatives of chlorochalcone as acetylcholinesterase (AChE) and buthylcholinesterase (BuChE) inhibitors: the influence of chlorine, alkyl amine side chain and α,β-unsaturated ketone group.
    Gao XH, Zhou C, Liu HR, Liu LB, Tang JJ, Xia XH.
    J Enzyme Inhib Med Chem; 2017 Dec; 32(1):146-152. PubMed ID: 27801600
    [Abstract] [Full Text] [Related]

  • 24. Synthesis, characterisation, DNA binding, acetylcholinesterase (AChE) and butyrylcholinesterase (BuChE) activities and molecular docking studies of metal(II) complexes with 1,10-phenanthroline scaffold.
    Gladis EHE, Nagashri K, Anisha M, Joseph J.
    J Biomol Struct Dyn; 2023 Jul; 41(11):5067-5085. PubMed ID: 35699274
    [Abstract] [Full Text] [Related]

  • 25. Design, synthesis, biological evaluation, and molecular dynamics of novel cholinesterase inhibitors as anti-Alzheimer's agents.
    Shamsimeymandi R, Pourshojaei Y, Eskandari K, Mohammadi-Khanaposhtani M, Abiri A, Khodadadi A, Langarizadeh A, Sharififar F, Amirheidari B, Akbarzadeh T, Lotfian H, Foroumadi A, Asadipour A.
    Arch Pharm (Weinheim); 2019 Jul; 352(7):e1800352. PubMed ID: 31136018
    [Abstract] [Full Text] [Related]

  • 26. The interactions of azure B, a metabolite of methylene blue, with acetylcholinesterase and butyrylcholinesterase.
    Petzer A, Harvey BH, Petzer JP.
    Toxicol Appl Pharmacol; 2014 Feb 01; 274(3):488-93. PubMed ID: 24161345
    [Abstract] [Full Text] [Related]

  • 27. Synthesis of New Triazole-Based Thiosemicarbazone Derivatives as Anti-Alzheimer's Disease Candidates: Evidence-Based In Vitro Study.
    Rahim F, Ullah H, Taha M, Hussain R, Sarfraz M, Iqbal R, Iqbal N, Khan S, Ali Shah SA, Albalawi MA, Abdelaziz MA, Alatawi FS, Alasmari A, Sakran MI, Zidan N, Jafri I, Khan KM.
    Molecules; 2022 Dec 20; 28(1):. PubMed ID: 36615218
    [Abstract] [Full Text] [Related]

  • 28. Graveoline Analogs Exhibiting Selective Acetylcholinesterase Inhibitory Activity as Potential Lead Compounds for the Treatment of Alzheimer's Disease.
    Li Z, Mu C, Wang B, Jin J.
    Molecules; 2016 Jan 22; 21(2):132. PubMed ID: 26805806
    [Abstract] [Full Text] [Related]

  • 29. Alignment-independent 3D-QSAR and molecular docking studies of tacrine-4-oxo-4H-Chromene hybrids as anti-Alzheimer's agents.
    Manouchehrizadeh E, Mostoufi A, Tahanpesar E, Fereidoonnezhad M.
    Comput Biol Chem; 2019 Jun 22; 80():463-471. PubMed ID: 31170562
    [Abstract] [Full Text] [Related]

  • 30. Bioactivity of hamamelitannin, flavokawain A, and triacetyl resveratrol as natural compounds: Molecular docking study, anticolon cancer, and anti-Alzheimer potentials.
    Zhang M, Xue J, Chen X, Elsaid FG, Salem ET, Ghanem RA, El-Kott AF, Xu Z.
    Biotechnol Appl Biochem; 2023 Apr 22; 70(2):730-745. PubMed ID: 35933706
    [Abstract] [Full Text] [Related]

  • 31. Design, Synthesis, and Cholinesterase Inhibition Assay of Coumarin-3-carboxamide-N-morpholine Hybrids as New Anti-Alzheimer Agents.
    Tehrani MB, Rezaei Z, Asadi M, Behnammanesh H, Nadri H, Afsharirad F, Moradi A, Larijani B, Mohammadi-Khanaposhtani M, Mahdavi M.
    Chem Biodivers; 2019 Jul 22; 16(7):e1900144. PubMed ID: 31155827
    [Abstract] [Full Text] [Related]

  • 32. Structure-activity relationship studies of benzyl-, phenethyl-, and pyridyl-substituted tetrahydroacridin-9-amines as multitargeting agents to treat Alzheimer's disease.
    Osman W, Mohamed T, Sit VM, Vasefi MS, Beazely MA, Rao PP.
    Chem Biol Drug Des; 2016 Nov 22; 88(5):710-723. PubMed ID: 27282589
    [Abstract] [Full Text] [Related]

  • 33. Design, synthesis and pharmacological evaluation of chalcone derivatives as acetylcholinesterase inhibitors.
    Liu HR, Liu XJ, Fan HQ, Tang JJ, Gao XH, Liu WK.
    Bioorg Med Chem; 2014 Nov 01; 22(21):6124-33. PubMed ID: 25260958
    [Abstract] [Full Text] [Related]

  • 34. Design, molecular Docking, synthesis and evaluation of xanthoxylin hybrids as dual inhibitors of IL-6 and acetylcholinesterase for Alzheimer's disease.
    Kaur S, Bansal Y.
    Bioorg Chem; 2022 Apr 01; 121():105670. PubMed ID: 35189442
    [Abstract] [Full Text] [Related]

  • 35. Novel biphenyl bis-sulfonamides as acetyl and butyrylcholinesterase inhibitors: Synthesis, biological evaluation and molecular modeling studies.
    Mutahir S, Jończyk J, Bajda M, Khan IU, Khan MA, Ullah N, Ashraf M, Qurat-ul-Ain, Riaz S, Hussain S, Yar M.
    Bioorg Chem; 2016 Feb 01; 64():13-20. PubMed ID: 26595185
    [Abstract] [Full Text] [Related]

  • 36. Design, synthesis, biological evaluation and molecular modeling of N-isobutyl-N-((2-(p-tolyloxymethyl)thiazol-4yl)methyl)benzo[d][1,3] dioxole-5-carboxamides as selective butyrylcholinesterase inhibitors.
    Xi M, Feng C, Du K, Lv W, Du C, Shen R, Sun H.
    Bioorg Med Chem Lett; 2022 Apr 01; 61():128602. PubMed ID: 35124202
    [Abstract] [Full Text] [Related]

  • 37. Synthesis and molecular docking studies of 5-trifluoromethoxy-2-indolinones as cholinesterase dual inhibitors.
    Soylu-Eter Ö, Özsoy N, Karalı N.
    Future Med Chem; 2024 Apr 01; 16(7):623-645. PubMed ID: 38470247
    [Abstract] [Full Text] [Related]

  • 38. Design, synthesis, biological evaluation and docking study of 5-oxo-4,5-dihydropyrano[3,2-c]chromene derivatives as acetylcholinesterase and butyrylcholinesterase inhibitors.
    Khoobi M, Alipour M, Sakhteman A, Nadri H, Moradi A, Ghandi M, Emami S, Foroumadi A, Shafiee A.
    Eur J Med Chem; 2013 Oct 01; 68():260-9. PubMed ID: 23988409
    [Abstract] [Full Text] [Related]

  • 39. Design, synthesis, biological evaluation and molecular docking of cyclic biguanidine compounds as cholinesterase inhibitors.
    Gungor O, Kose M.
    J Biomol Struct Dyn; 2023 Dec 01; 41(20):10885-10899. PubMed ID: 36537267
    [Abstract] [Full Text] [Related]

  • 40. Insights into the Role of Erythrina corallodendron L. in Alzheimer's Disease: in Vitro and in Silico Approach.
    Salem AM, Mostafa NM, Al-Sayed E, Fawzy IM, Singab ANB.
    Chem Biodivers; 2023 Jul 01; 20(7):e202300200. PubMed ID: 37329524
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.